跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Buticod - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Buticod
Approved
STANDARD
Buticod
Lloyd Laboratories, Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
3ccc6619554fdc71
Company
Lloyd Laboratories, Inc.
Type
Standard
Approval Details
Approval Id
3ccc6619554fdc71
Drug Approval Philippines Name
Buticod
Product Name
Buticod
Registration Number
DRP-6725-03
Brand Name
Buticod
Generic Name
Butamirate (As Citrate)
Dosage Form
Sustained-Release Tablet
Dosage Strength
50 mg
Manufacturer
Lloyd Laboratories, Inc.
Importer
D.B. Manix International, Inc.
Distributor
Westfield Pharmaceuticals, Inc.
Issuance Date
30 January 2022
Expiry Date
16 February 2027
Pharmacologic Category
Antitussive
Classification
Over-The-Counter (OTC)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
3ccc6619554fdc71
Type
Standard
Back to Philippines FDA Approvals